Dr. Xiuning Le, M.D., Ph.D.
Claim this profileM D Anderson Cancer Center
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
13 reported clinical trials
19 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
MET positive
Stage III
Stage IV
2Lung Cancer
EGFR positive
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Xiuning Le, M.D., Ph.D. is currently running
TAS3351
for Non-Small Cell Lung Cancer
This trial is testing a new drug called TAS3351 to see if it is safe and effective for patients with advanced lung cancer that has a specific genetic mutation. The drug works by blocking a protein that helps cancer cells grow.
Recruiting1 award Phase 1 & 27 criteria
Amivantamab + Tepotinib
for Lung Cancer
To learn if the combination of amivantamab and tepotinib can help to control NSCLC. The safety of this drug combination will also be studied.
Recruiting1 award Phase 1 & 229 criteria
More about Xiuning Le, M.D., Ph.D.
Clinical Trial Related3 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Xiuning Le, M.D., Ph.D. has experience with
- Osimertinib
- Tepotinib
- Cisplatin
- Docetaxel
- Amivantamab
- OSI-774
Breakdown of trials Xiuning Le, M.D., Ph.D. has run
Non-Small Cell Lung Cancer
Lung Cancer
Skin Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Xiuning Le, M.D., Ph.D. specialize in?
Xiuning Le, M.D., Ph.D. focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved MET positive patients, or patients who are Stage III.
Is Xiuning Le, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Xiuning Le, M.D., Ph.D. is currently recruiting for 5 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Xiuning Le, M.D., Ph.D. has studied deeply?
Yes, Xiuning Le, M.D., Ph.D. has studied treatments such as Osimertinib, Tepotinib, Cisplatin.
What is the best way to schedule an appointment with Xiuning Le, M.D., Ph.D.?
Apply for one of the trials that Xiuning Le, M.D., Ph.D. is conducting.
What is the office address of Xiuning Le, M.D., Ph.D.?
The office of Xiuning Le, M.D., Ph.D. is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.